These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8331898)

  • 41. Fibrinogen, fibrin and the arterial wall.
    Smith EB
    Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The physiological significance of the endoendothelial fibrin lining (EEFL) as the critical interface in the "vessel-blood organ' and the importance of in vivo "fibrinogenin formation' in health and disease.
    Copley AL
    Thromb Res; 1983; Suppl 5():105-45. PubMed ID: 6225215
    [No Abstract]   [Full Text] [Related]  

  • 43. [Functional interaction of protective systems in the blood].
    Sushkevich GN
    Lab Delo; 1979; (12):707-11. PubMed ID: 93158
    [No Abstract]   [Full Text] [Related]  

  • 44. Haematology, haemostasis, and tissue repair.
    Astrup T
    Haematologica; 1975 Sep; 60(3):257-68. PubMed ID: 812781
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of coagulation by fibrinopeptides released during fibrinolysis.
    Schneider CL; Engstrom RM
    Bibl Anat; 1969; 10():469-73. PubMed ID: 5407402
    [No Abstract]   [Full Text] [Related]  

  • 46. Different contribution of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation.
    von Känel R; Kudielka BM; Hanebuth D; Preckel D; Fischer JE
    Clin Sci (Lond); 2005 Jul; 109(1):61-7. PubMed ID: 15752067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
    Lewis MR; Callas PW; Jenny NS; Tracy RP
    Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of fibrinolysis and coagulation in the glomerulus in the course of rat Masugi Nephritis -- studies employing the isolated glomeruli -- (author's transl)].
    Kawaguchi N
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1175-99. PubMed ID: 748641
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemostatic system in diabetes in children and in adults].
    Prochorow M; Fiederowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Pol Tyg Lek; 1977 Feb; 32(8):317-9. PubMed ID: 840755
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibrinogen-fibrin degradation products in uterine and peripheral blood during Caesarean section.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():1-7. PubMed ID: 4599651
    [No Abstract]   [Full Text] [Related]  

  • 51. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Coagulation and fibrinolysis in interstitial lung diseases].
    Tałałaj J; Chyczewska E
    Pneumonol Alergol Pol; 1999; 67(3-4):146-50. PubMed ID: 10497448
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coagulation and fibrinolysis system in bladder tumor. 1. Urinary FDP and fibrin deposition around the tumor].
    Nagai N
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):20-30. PubMed ID: 4010109
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrin as a factor in atherogenesis.
    Smith EB; Thompson WD
    Thromb Res; 1994 Jan; 73(1):1-19. PubMed ID: 8178309
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local intravascular coagulation and fibrin deposition on intestinal ischemia-reperfusion in rats.
    Schoots IG; Levi M; Roossink EH; Bijlsma PB; van Gulik TM
    Surgery; 2003 Apr; 133(4):411-9. PubMed ID: 12717359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of certain semiquantitative methods of determination of the content of fibrin-fibrinogen degradation products in blood plasma].
    Andreenko GV; Podorol'skaia LV
    Lab Delo; 1976; (1):3-7. PubMed ID: 56485
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrinogen-fibrin degradation products during labour and during the puerperium.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():1-6. PubMed ID: 4525174
    [No Abstract]   [Full Text] [Related]  

  • 60. [Interaction of low density lipoproteins with fibrinogen and basic proteins].
    Skrzydlewski Z; Wiśniewski L; Głowiński S; Worowski K
    Patol Pol; 1979; 30(3):415-20. PubMed ID: 232260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.